Catalyst Wire Dossier Catalyst Wire Dossier

Pegzilarginase

pegzilarginase · Aeglea Biotherapeutics
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Pegzilarginase, covering 2021-11-04 to 2025-11-28. Get the full timeline:

Most recent: Clinical Trial Update: Pegzilarginase in Subjects <24 Months Old With Arginase 1 Deficiency [Phase 3]

See pricing